Good MorningEquity markets were flat on Wednesday as markets digested the previous day's gains. The S&P hovered near an all-time high and may move up to set a new high soon, but there is risk. The rally has become long in the tooth and ready to correct. The S&P 500 is setting new highs but diverging from indicators, suggesting growing weakness within the market. In this scenario, a small 5% 5o 10% correction would be healthy and set the market up to resume the rally by mid-year.
Tech continues to drag on the markets. Rallies in NVIDIA, Advanced Micro Devices, Meta Platforms, and other mega-cap tech were driving the rally but are now struggling with resistance. If these stocks can't sustain their uptrends, the S&P 500 will likely stall at current levels. With mega-caps looking overbought, investors have begun to turn to small and mid-caps where value can be found. Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Basic Materials | |
As the market continues its relentless ascent to new heights, propelled by the surging tech sector and hype surrounding AI, the murmurs of potential interest rate cuts by the Federal Reserve continue, and investors find themselves at a juncture where prudence meets opportunity.
Amid this euphor... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Technology | |
Comcast Corp. (NASDAQ: CMCSA), Charles Schwab Corp. (NYSE: SCHW) and Alphabet Inc. (NASDAQ: GOOGL) are among institutional-quality large-cap stocks that are currently undervalued.
There are a few reasons why institutions continue showing conviction when it comes to stocks priced below where their... Read the Full Story |
|
Finance | |
The world economy has gone online; there is no turning back from this fact. The only question is how you can profit from this transition. Because more players have become dependent on cybersecurity, the World Economic Forum (WEF) is slowly making this an important theme. Today, you can get ahead o... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Business Services | |
The price action in Airship AI Holdings (NASDAQ: AISP) spiked 500% in two days, bringing it to the attention of MarketBeat's unusual trading activity sensors. The spike was accompanied by a 500X increase in volume that promises to keep this stock moving higher.
Why will AirshipAI move higher? Be... Read the Full Story |
|
Retail/Wholesale | |
As digital media expands and personal file collections grow, cloud computing stocks have become a major focal point for investors. This industry, vital for global connectivity and collaboration, has experienced steady growth, particularly highlighted during the ongoing digital transformation spurr... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Retail/Wholesale | |
Williams-Sonoma’s (NYSE: WSM) stock surge is due to its persistent outperformance and quality business. The company contracted in 2023 along with the housing market, but cash flow remained solid, driving substantial capital returns for investors. The Q4 results continue the trend and point t... Read the Full Story |
|
Finance | |
Investment houses like The Goldman Sachs Group Inc. (NYSE: GS) have an average winning ratio of over 85% in their trading business. You can wonder how they achieve these results, or you can rest assured that their idea-generation process relies heavily on a “top-down” analysis. Today, ... Read the Full Story |
|
Retail/Wholesale | |
Casey’s General Store (NASDAQ: CASY) peaked ahead of its FQ3 release and is correcting afterward, but don’t think the sell-off will continue for long. The company’s results were tepid and mixed but revealed resiliency in a business model that has delivered value to shareholders f... Read the Full Story |
|
Retail/Wholesale | |
The stock market has absolutely, 100% priced in a rate cut. The market has been expecting a rate cut for more than a year and is, in fact, pricing in a soft landing and sustained economic growth. The question that needs to be answered is whether the market is mispricing a rate cut, and the answer ... Read the Full Story |
|
Medical | |
They may not be household names like Meta Platforms Inc. (NASDAQ: META) or investor favorites like Nvidia Corp. (NASDAQ: NVDA), but several small stocks, such as Ultra Clean Holdings, Inc. (NASDAQ: UCTT), Powell Industries Inc. (NASDAQ: POWL) and AdaptHealth Corp. (NASDAQ: AHCO) are outperforming ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, an intravenous-administered antibiotic against MDR Gram-negative pathogens comprising carbapenem-resistant enterobacterales (CRE), acinetobacter baumannii, and pseudomonas aeruginosa, as well as negative bacterial infections in the hospital setting; and SPR720, a novel oral antibiotic agent for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
